N112-DOTAP LNP

N112-DOTAP LNP is a lipid nanoparticle (LNP) formulation containing the cationic lipid DOTAP (1,2-dioleoyl-3-trimethylammonium-propane) engineered to encapsulate and deliver nucleic acid cargo such as mRNA, DNA, or proteins into target cells. DOTAP-based LNPs leverage permanent positive charge for efficient complexation and cellular uptake of negatively charged nucleic acids, while additional components such as cholesterol and phospholipids like DOPE can be present to optimize stability, biodistribution, and endosomal escape. These LNPs are employed in research and development of vaccines, gene therapies, and protein delivery, and their mechanism of action is physical encapsulation and delivery via cellular uptake, followed by endosomal escape and cytoplasmic cargo release. Precise composition and manufacturing method (including ratios of DOTAP and other lipids) impact tissue targeting, efficacy, and safety. N112-DOTAP LNP may refer to a proprietary or custom lipid nanoparticle formulation within an experimental or preclinical context, as no marketed product or clinical trial is specifically indexed under this exact designation in current literature.[3][6][1]